SW

Sean Williams

Nexalis Therapeutics Ltd | Non-Executive Chairman, Non-Executive Director
Mr Williams has over 30 years of experience in senior executive and finance roles across the pharmaceutical, healthcare, investment management and supply chain sectors. Having commenced his career with an international accounting firm, Sean has held a number of senior roles including General Manager, Finance for Symbion Pharmacy (Australia's pharmaceutical wholesaler). He also headed up Symbion's hospital pharmacy and dental divisions and was responsible for Independent Pharmacy Solutions (a short-line wholesale business). Sean has worked as an investment director in private equity and as a senior executive in private equity backed ventures. He has also led management buy-outs and been involved in founding start-up businesses within the supply chain sector. Most recently, Sean was CEO of a $500m investment management business in Australian agricultural investments.

Company and Roles

Company
Title
Tenure
Since
NX1
Nexalis Therapeutics Ltd
  • Non-Executive Chairman
  • Non-Executive Director
4yrs, 11mthJul 2021

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NX1
Nexalis Therapeutics Ltd
31/12/25N/A983,9206,021,389N/A
23/12/250983,9206,021,389N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NX1
Nexalis Therapeutics Ltd
14/07/26
Issued
2,641,477$0.016$42,263Director remuneration
NX1
Nexalis Therapeutics Ltd
17/02/26
Issued
1,851,567$0.023$42,586Director remuneration
NX1
Nexalis Therapeutics Ltd
23/12/25
Issued
42,777$0.025$1,069Rights issue
NX1
Nexalis Therapeutics Ltd
23/12/25
Issued
21,389$0.023$491Rights issue
23/12/25
Issued
21,389$0.023$491Rights issue